MicroRNAs as a target for novel antipsychotics: A systematic review of an emerging field

International Journal of Neuropsychopharmacology

Volumn 13, Issue 3, 2010, Pages 395-404

  Dinan, Timothy G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antipsychotics; Bipolar affective disorder; MicroRNA; Novel treatments; Schizophrenia

Indexed keywords

DIZOCILPINE; HALOPERIDOL; LITHIUM; MICRORNA; MICRORNA 144; MICRORNA 181; MICRORNA 195; MICRORNA 219; MICRORNA 346; MICRORNA 34A; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

BIPOLAR DISORDER; DRUG PROTEIN BINDING; DRUG TARGETING; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDLINE; MICROARRAY ANALYSIS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY RNA SEQUENCE; REVIEW; SCHIZOPHRENIA; STRESS;

ANIMALS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM; DATABASES, FACTUAL; DRUG DESIGN; HUMANS; MENTAL DISORDERS; MICRORNAS;

EID: 77953535638     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990800     Document Type: Review

References (86)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, et al. (2005). Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310, 317-320.
2. Angelucci F, Aloe L, Jimenez-Vasquez P, Mathe AA (2003). Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. International Journal of Neuropsychopharmacology 6, 225-231. (Pubitemid 37248000)
3. Arnold SE, Talbot K, Hahn CG (2005). Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Progress in Brain Research 147, 319-345.
4. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, et al. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Human Molecular Genetics 17, 1156-1168.
5. Bicker S, Schratt G (2008). microRNAs: tiny regulators of synaptic function in development and disease. Journal of Cellular and Molecular Medicine 12, 1466-1476.
6. Brasnjevic I, Steinbusch HWM, Schmitz C, Martinez-Martinez P (2009). Delivery of peptide and protein drugs over the blood-brain-barrier. Progress in Neurobiology 87, 212-251.
7. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, et al. (2007). MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Moscow) 72, 578-582.
8. Butzlaff RL, Hooley JM (1997). Expressed emotion and psychiatric relapse: a meta-analysis. Archives of General Psychiatry 55, 547-552.
9. Cao X, Pfaff SL, Gage FH (2007). A functional study of miR-124 in the developing neural tube. Genes and Development 21, 531-536.
10. Chang S, Johnston Jr. RJ, Frokjaer-Jensen C, Lockery S, Hobert O (2004). MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode. Nature 430, 785-789.
11. Chen G, Manji HK, Hawver DB, Wright CB, Potter WZ (1994). Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. Journal of Neurochemistry 63, 2361-2364.
12. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK (2000). Enhancement of hippocampal neurogenesis by lithium. Journal of Neurochemistry 75, 1729-1734.
13. Chen G, Zeng WZ, Yuan PX, Huang LD, et al. (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry 72, 879-882.
14. Cheng HY, Papp JW, Varlamova O, Dziema H, et al. (2007). MicroRNA modulation of circadian-clock period and entrainment. Neuron 54, 813-829.
15. Conaco C, Otto S, Han JJ, Mandel G (2006). Reciprocal actions of REST and a microRNA promote neuronal identity. Proceedings National Academy of Sciences USA 103, 2422-2427.
16. Coyle JT (2009). MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia. Proceedings of the National Academy of Sciences USA 106, 2975-2976.
17. Dinan TG (1994). Glucocorticoids in the genesis of depressive illness: A psychobiological model. British Journal of Psychiatry 164, 365-371.
18. Douglas J, Guarnieri J, Dilbone RJ (2008). MicroRNAs: a new class of gene regulators. Trends in Molecular Medicine 40, 197-208.
19. Farh KK, Grimson A, Jan C, Lewis BP, et al. (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310, 1817-1821.
20. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 9, 102-114.
21. Fiore R, Siegel G, Schratt G (2008). MicroRNA function in neuronal development, plasticity and disease. Biochimica et Biophysica Acta 1779, 471-478.
22. Frey BN, Andreazza AC, Cereser KM, Martins MR, et al. (2006). Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sciences 79, 281-286.
23. Frith MC, Pheasant M, Mattick JS (2005). The amazing complexity of the human transcriptome. European Journal of Human Genetics 13, 894-897.
24. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001). Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berlin) 158, 100-106.
25. Gao FB (2008). Posttranscriptional control of neuronal development by microRNA networks. Trends in Neurosciences 31, 20-26.
26. Ghildiyal M, Zamore PD (2009). Small silencing RNAs: an expanding universe. Nature Reviews Genetics 10, 94-108.
27. Goodwin FK, Jamison KR (2007). Manic-Depressive Illness: Bipolar and Recurrent Unipolar Disorders, 2nd edn. New York: Oxford University Press.
28. Gould TD, Einat H, O'Donnell KC, Picchini AM, et al. (2007). Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 32, 2173-2183.
29. Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK (2004). Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Molecular Psychiatry 9, 734-755.
30. Greco SJ, Rameshwar P (2007). MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell derived neuronal cells. Proceedings of the National Academy of Sciences USA 104, 15484-15489.
31. Guarnieri DJ, DiLeone RJ (2008). MicroRNAs: a new class of gene regulators. Annals of Medicine 40, 197-208.
32. Hansen T, Olsen L, Lindow M, Jakobsen KD, et al. (2007). Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2, e873.
33. Hao Y, Creson T, Zhang L, Li P, et al. (2004). Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. Journal of Neuroscience 24, 6590-6599.
34. Haupt DW, Kane JM (2007). Metabolic risks and effects of atypical antipsychotic treatment. Journal of Clinical Psychiatry 68, e24.
35. Hobert O (2008). Gene regulation by transcription, factors and microRNAs. Science 319, 1785-1786.
36. Huang W, Li MD (2008). Nicotine modulates expression of miR-140&z.ast;, which targets the 3'-untranslated regions of dynamin 1 gene (Dnm1). International Journal of Neuropsychopharmacology 12, 537-546.
37. Huang W, Li MD (2009). Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biological Psychiatry 65, 702-705.
38. Hunsberger JG, Austin DR, Chen G, Manji HK (2009). MicroRNAs in mental health: From biological underpinnings to potential therapies. Neuromolecular Medicine 11, 173-182.
39. Jacobsen JP, Mork A (2004). The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Research 1024, 183-192.
40. John B, Enright AJ, Aravin A, Tuschl T, et al. (2004). Human MicroRNA targets. PLoS Biology 2, e363.
41. Johnston RJ, Hobert O (2003). A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature 426, 845-849.
42. Kim JS, Chang MY, Yu IT, Kim JH, et al. (2004). Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. Journal of Neurochemistry 89, 324-336.
43. Kim VN, Han J, Siomi MC (2009). Biogenesis of small RNAs in animals. Nature Reviews Molecular Cell Biology 10, 126-139.
44. Kocerha J, Faghihi MA, Lopez-Toledano MA, Huang J, et al. (2006). The neuronal microRNA system. Nature Reviews Neuroscience 7, 911-920.
45. Kochera J, Faghihi MA, Lopez-Toledano MA, Huang J, et al. (2009). MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proceedings of the National Academy of Sciences USA 106, 2975-2976.
46. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS (2006). Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24, 857-864.
47. Krü tzfeldt J, Rajewsky N, Braich R, Rajeev KG, et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. ature 438, 685-689.
48. Laeng P, Pitts RL, Lemire AL, Drabik CE, et al. (2004). The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. Journal of Neurochemistry 91, 238-251.
49. Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854.
50. Leung AK, Sharp PA (2006). Function and localization of microRNAs in mammalian cells. Cold Spring Harbour Symposium on Quantitative Biology 71, 29-38.
51. Lewis BP, Burge CB, Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
52. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003). Prediction of mammalian microRNA targets. Cell 115, 787-798.
53. Lugli G, Larson J, Martone ME, Jones Y, Smalheiser NR (2005). Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. Journal of Neurochemistry 94, 896-905.
54. Manji HK, Etcheberrigaray R, Chen G, Olds JL (1993). Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme. Journal of Neurochemistry 61, 2303-2310.
55. Martin G, Schouest K, Kovvuru P, Spillane C (2007). Prediction and validation of microRNA targets in animal genomes. Journal of Bioscience 32, 1049-1052.
56. Mehler MF, Mattick JS (2006). Non-coding RNAs in the nervous system. Journal of Physiology 575, 333-341.
57. Mellios N, Huang HS, Baker SP, Galdzicka M, et al. (2009). Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 65, 1006-1014.
58. Mellios N, Huang H-S, Grigorenko A, Rogaev E, Akbarian S (2008). A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Human Molecular Genetics 17, 3030-3042.
59. Murray CLJ, Lopez AD (eds.)(1996). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston: Harvard University Press.
60. Novina CD, Sharp PA (2004). The RNAi revolution. Nature 430, 161-164.
61. Perkins DO, Jeffries C, Sullivan P (2005). Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Molecular Psychiatry 10, 69-78.
62. Paykel ES (1998). Memories of drug development. In: Ban TA, Healy D, Shorter E (Eds), The Rise of Psychopharmacology and the Story of CINP (pp. 168-171). Budapest: Animula.
63. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, et al. (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biology 8, R27.
64. Pietrzykowski A, Friesen RM, Martin GE, Puig SI, et al. (2008). Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 59, 274-287.
65. Pushparaj PN, Aarthi JJ, Manikandan J, Kumar SD (2008). siRNA, miRNA and shRNA: in vivo applications. Journal of Dental Research 87, 992-1003.
66. Rogaev EI (2005). Small RNAs in human brain development and disorders. Biochemistry (Moscow) 70, 1404-1407.
67. Roybal K, Theobold D, Graham A, DiNieri JA, et al. (2007). Mania-like behavior induced by disruption of CLOCK. Proceedings of the National Academy of Sciences USA 104, 6406-6411.
68. Schloesser RJ, Huang J, Klein PS, Manji HK (2008). Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 110-133.
69. Schratt GM, Tuebing F, Nigh EA, Kane CG, et al. (2006). A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289.
70. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, et al. (2004). Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biology 5, R13.
71. Shibata H, Tani A, Chikuhara T, Kikuta R, et al. (2009). Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia. Psychiatry Research 167, 88-96.
72. Smalheiser NR (2008). Regulation of mammalian microRNA processing and function by cellular signalling and subcellular localisation. Biochimica et Biophysica Acta 1779, 678-681.
73. Smith M (2009). The year in human and medical genetics. Highlights of 2007-2008. Annals of the New York Academy of Sciences 1151, 1-21.
74. Son H, Yu IT, Hwang SJ, Kim JS, et al. (2003). Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus. Journal of Neurochemistry 85, 872-881. (Pubitemid 36578619)
75. Stark KL, Xu B, Bagchi A, Lai WS, et al. (2008). Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nature Genetics 40, 751-760.
76. Taylor DM, Douglas-Hall P, Olofinjana B, Whiskey E, Thomas A (2009). Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. British Journal of Psychiatry 194, 468-469.
77. Uchida S, Nishida A, Hara K, Kamemoto T, et al. (2008). Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. European Journal of Neuroscience 27, 2250-2261.
78. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes and Development 20, 515-524.
79. Visvanathan J, Lee S, Lee B, Lee JW, Lee SK (2007). The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes and Development 21, 744-749.
80. Vo N, Klein ME, Varlamova O, Keller DM, et al. (2005). A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proceedings National Academy of Sciences USA 102, 16426-16431.
81. Vreugdenhil E, Verissimo CSL, Mariman R, Kamphorst JT, et al. (2009). MicroRNAs miR-18 and miR-124a downregulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 150, 2220-2228.
82. Xu T, Zhu Y, Xiong Y, Ge YY, Zung ZP, Zhuang SM (2009). MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50, 113-121.
83. Zeng Y (2009). Regulation of the mammalian nervous system by microRNAs. Molecular Pharmacology 75, 259-264.
84. Zhou R, Gray NA, Yuan P, Li X, Chen J, et al. (2005). The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. Journal of Neurochemistry 25, 4493-4502.
85. Zhou R, Yuan P, Wang Y, Hunsberger JG, et al. (2009). Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34, 1395-1405.
86. Zhu Y, Kalbfleisch T, Brennan MD, Li Y (2009). A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophrenia Research 109, 86-89.